Heart attacks, medically known as myocardial infarctions, remain one of the leading causes of death and long-term disability worldwide. Advances in emergency treatment and cardiac care have significantly improved survival rates, but surviving a heart attack is often only the beginning of a long health journey. Many patients experience weakened heart function after a myocardial infarction, particularly in the left ventricle, the heart’s primary pumping chamber. This reduced pumping capacity can lead to the development of heart failure, a chronic condition that severely affects quality of life and increases the likelihood of hospital readmissions. Recent clinical research suggests that stem cell therapy could play a transformative role in preventing post-heart attack complications. A stud

See Full Page